Dr John Feenstra had the privilege of being an international speaker at this prestigious event held in Bangkok, where he shared valuable insights on sotatercept, a cutting-edge treatment for pulmonary arterial hypertension (PAH), through the Wesley Research Institute clinical trial program.
Pulmonary Hypertension is a serious condition characterised by high blood pressure in the blood vessels of the lungs. Unlike regular blood pressure measured in the arm, PH refers to the pressure inside the vessels within the lungs. This elevated lung pressure causes patients to feel short of breath and, if left untreated, can ultimately lead to right heart failure and death.
Dr John Feenstra, head of the Pulmonary Hypertension Research Program and his team at Wesley Research Institute, are looking to change that by conducting clinical trials that aim to provide early treatments individually tailored to give patients better outcomes.
🎤 During his session, John highlighted the transformative results from sotatercept clinical trials, demonstrating how it has the potential to:
- Improve exercise capacity
- Reduce clinical worsening events
- Slow PAH progression for certain patients
In addition, Dr Feenstra took the stage for his second lecture, “Sotatercept in Action: Compelling PAH Case Studies”, where he shared powerful patient stories from clinical studies at Wesley Research Institute. These real-world cases highlighted how clinical trial data isn’t just numbers; it’s a game-changer in transforming patient care, providing tangible improvements in quality of life for those with PAH.
The visit emphasised the importance of global collaboration in pulmonary hypertension research, while also contributing to broader discussions on the future role of sotatercept in managing pulmonary arterial hypertension. Events such as these lay the foundation for future partnerships aimed at advancing clinical trials and improving pulmonary hypertension patient care.
Discover more about the life-changing work of the Pulmonary Hypertension Research Program at Wesley Research Institute.
